Upload
flavio-guzman
View
21
Download
4
Embed Size (px)
DESCRIPTION
Citation preview
Prostaglandins & NSAIDs
Cheryl TajonOctober 13, 2008
Review Session: Exam 1Walter Holleran
Lehninger Principles of Biochemistry, 3rd Edition, Nelson, D. and Cox, M., p.378
Formation of Eicosanoids
1° pathway
Lehninger Principles of Biochemistry, 3rd Edition, Nelson, D. and Cox, M., p.378
Formation of Eicosanoids
1° pathway
C20:4 or 20:4∆5, 8, 11, 14
Essential fatty acids (EFA’s)
912
Cyclooxygenase (COX) mechanism
COX-2 PDB = 6COX
Cyclooxygenase (COX) mechanism
COX-2 PDB = 6COX
I
1 unsaturated bond
Saturated
I
1 unsaturated bond
Saturated
Bridged bicyclic system 2 fused rings
Bridged bicyclic system
ω-3 FA’s (like PGE3) are generated from eicosapentaenoic acid.
•Induces uterine contractions•Prepares cervix for labor & delivery•Induces abortion (1st & 2nd trimester)
•PGI2 analogue•Treats hypertension•Disadvantage: requires a central line•Short half-life (3-5 min)
•Treats impotence•Given as an injection or urethral suppository
•Synthetic PGE1 analogue•Prevents NSAID-induced ulcers•C16 methyl increases stability and half-life
Arachidonic acid
COX
Present in blood platelets
Thromboxanes induce constriction of blood vessels and platelet aggregation (blood clotting).
Low doses of aspirin, taken regularly, reduce the probability of heart attacks and strokes.Lehningher Principles of Biochemistry, 3rd Ed., p.785
COX: “cyclic” pathway
Lipoxygenase: “linear” pathway; found in leukocytes; incorporates molecular oxygen into arachidonate (5-hydroperoxyeicosatetraenoate)
Chemoattractant for neutrophils
Arachidonic acid
lipoxygenase
What conditions are NSAIDs used?
• 1o: treat inflammation, mild to moderate pain, & fever
• Specific uses: headaches, arthritis, sports injuries, menstrual cramps
• Included in cold/allergy preparations
Molecular target for NSAIDs
•COX is a homodimer.•Active sites for COX1 & 2 are different.
•COX2 has an extended binding pocket that can be utilized for selectivity.
•All COX inhibitors, regardless of selectivity, bind in the arachidonic acid binding site.
TiPS – Nov 1999 (vol. 20)
• Inhibits by acetylating a serine residue in the active site.
Prototype NSAIDs
CO2H
O
O
Aspirin
HO Ser
Enzyme
Acetylation
CO2H
OH
Salicylic acid
+O
O
Ser
Enzyme
•However, NSAIDs can also inhibit synthesis of beneficial prostaglandins in GI tract and kidney.
acid
Critical single carbon bridge
•Ibuprofen•(S) is the active enantiomer.
•Less potent, more liver toxicity w/o -CH3 group
Aryl Propionic Acidsnaphthalene
isobutyl
Indole Acids
COX has two isozymes.
• Both carry out the same reactions, but
COX-1
Active under normal healthy conditions
COX-2
Normally dormant; when activated produces excess
inflammatory prostaglandins
H2NO2S
NO
Valdecoxib
MeO2S
O
O
Refecoxib
H2NO2S
NN
CF3
Celecoxib
Selective COX-2 inhibitors:
Flurbiprofen
DuP 697
General structure for COX2 Selective NSAIDs
• Consist of a central ring with 1,2-biaryl substitution
X X
S
F
SO2CH3
Br
DuP 697
NN
F
SO2CH3
CF3
SC 58125
F
SO2CH3
F
SO2CH3
SC 57666
Acetaminophen Toxicity
Leukotriene Synthesis
•Targeting FLAP will inhibit 5-lipoxygenase
•Inhibits synthesis of leukotrienes•Approved 10yrs ago for asthma
Arachidonic acid
lipoxygenase
•Not much SAR
•Asthma•Can take orally
•Recently approved•Less effective than steroids
•Present at physiological pH.•Develop antagonists of this species against H1
receptor.
Basic N
Linker; variability in X & Y
Usually methyl, but not always
1st generation antihistamines crossed blood-brain barrier.
Basic N
X
•Weakly or non-sedating•Don’t cross blood-brain barrier•Both compounds are metabolized by Cyt P450.
•Prodrug•No longer used
•Active drug•Not converted in the reverse fashion
All are competitive and bind with increased affinity for TNFα.Humira
Remicade
Enbrel
Important in gout; used in combination with methotrexate.
Purpose: to reduce binding of leukocytes to the endothelium